Levels of Anti-Retinal Antibodies in Retinal Detachment and Proliferative Vitreoretinopathy

References

• Casaroli-Marano RP, Pagan R, Vilaro S. Epithelial-mesenchymal transition in proliferative vitreoretinopathy: intermediate filament protein expression in retinal pigment epithelial cells. Invest Ophthalmol Vis Sci.1999;40:2062–72.
   PubMed Web of Science ®Google Scholar
• Tamiya S, Kaplan HJ. Role of epithelial-mesenchymal transition in proliferative vitreoretinopathy. Exp Eye Res. 2016;142:26–31. doi:10.1016/j.exer.2015.02.008.
   PubMed Web of Science ®Google Scholar
• Pennock S, Haddock LJ, Eliott D, Mukai S, Kazlauskas A. Is neutralizing vitreal growth factors a viable strategy to prevent proliferative vitreoretinopathy? Prog Retin Eye Res. 2014;40:16–34. doi:10.1016/j.preteyeres.2013.12.006.
   PubMed Web of Science ®Google Scholar
• Limb GA, Little BC, Meager A, Ogilvie JA, Wolstencroft RA, Franks WA, Chignell AH, Dumonde DC. Cytokines in proliferative vitreoretinopathy. Eye (Lond). 1991;5(Pt 6):686–93. doi:10.1038/eye.1991.126.
   PubMedGoogle Scholar
• El-Ghrably IA, Dua HS, Orr GM, Fischer D, Tighe PJ. Intravitreal invading cells contribute to vitreal cytokine milieu in proliferative vitreoretinopathy. Br J Ophthalmol. 2001;85:461–70. doi:10.1136/bjo.85.4.461.
   PubMed Web of Science ®Google Scholar
• Garweg JG, Tappeiner C, Halberstadt M. Pathophysiology of proliferative vitreoretinopathy in retinal detachment. Surv Ophthalmol. 2013;58:321–29. doi:10.1016/j.survophthal.2012.12.004.
   PubMed Web of Science ®Google Scholar
• Limb GA, Alam A, Earley O, Green W, Chignell AH, Dumonde DC. Distribution of cytokine proteins within epiretinal membranes in proliferative vitreoretinopathy. Curr Eye Res. 1994;13:791–98. doi:10.3109/02713689409025133.
   PubMed Web of Science ®Google Scholar
• Kunikata H, Nishida K. Visual outcome and complications of 25-gauge vitrectomy for rhegmatogenous retinal detachment; 84 consecutive cases. Eye (Lond). 2010;24:1071–77. doi:10.1038/eye.2010.41.
   PubMed Web of Science ®Google Scholar
• Wakabayashi T, Oshima Y, Fujimoto H, Murakami Y, Sakaguchi H, Kusaka S, Tano Y. Foveal microstructure and visual acuity after retinal detachment repair: imaging analysis by Fourier-domain optical coherence tomography. Ophthalmology. 2009;116:519–28. doi:10.1016/j.ophtha.2008.10.001.
   PubMed Web of Science ®Google Scholar
• Abouzeid H, Wolfensberger TJ. Macular recovery after retinal detachment. Acta Ophthalmol Scand. 2006;84:597–605. doi:10.1111/j.1600-0420.2006.00676.x.
   PubMedGoogle Scholar
• Adamus G, Ren G, Weleber RG. Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy. BMC Ophthalmol. 2004;4:5. doi:10.1186/1471-2415-4-5.
   PubMedGoogle Scholar
• Grange L, Dalal M, Nussenblatt RB, Sen HN. Autoimmune retinopathy. Am J Ophthalmol. 2014;157(266–72):e1. doi:10.1016/j.ajo.2013.09.019.
   PubMed Web of Science ®Google Scholar
• Polans AS, Witkowska D, Haley TL, Amundson D, Baizer L, Adamus G. Recoverin, a photoreceptor-specific calcium-binding protein, is expressed by the tumor of a patient with cancer-associated retinopathy. Proc Natl Acad Sci U S A. 1995;92:9176–80. doi:10.1073/pnas.92.20.9176.
   PubMed Web of Science ®Google Scholar
• Heckenlively JR, Ferreyra HA. Autoimmune retinopathy: a review and summary. Semin Immunopathol. 2008;30:127–34. doi:10.1007/s00281-008-0114-7.
   PubMed Web of Science ®Google Scholar
• Brinkman CJ, Pinckers AJ, Broekhuyse RM. Immune reactivity to different retinal antigens in patients suffering from retinitis pigmentosa. Invest Ophthalmol Vis Sci.1980;19:743–50.
   PubMed Web of Science ®Google Scholar
• Yamamoto JH, Okajima O, Mochizuki M, Shinohara T, Wiggert B, Chader GJ, Gery I, Nussenblatt RB. Cellular immune responses to retinal antigens in retinitis pigmentosa. Graefes Arch Clin Exp Ophthalmol. 1992;230:119–23. doi:10.1007/BF00164648.
   PubMed Web of Science ®Google Scholar
• Heckenlively JR, Solish AM, Chant SM, Meyers-Elliott RH. Autoimmunity in hereditary retinal degenerations. II. Clinical studies: antiretinal antibodies and fluorescein angiogram findings. Br J Ophthalmol. 1985;69:758–64. doi:10.1136/bjo.69.10.758.
   PubMed Web of Science ®Google Scholar
• Heckenlively JR, Fawzi AA, Oversier J, Jordan BL, Aptsiauri N. Autoimmune retinopathy: patients with antirecoverin immunoreactivity and panretinal degeneration. Arch Ophthalmol. 2000;118:1525–33. doi:10.1001/archopht.118.11.1525.
   PubMedGoogle Scholar
• Patel N, Ohbayashi M, Nugent AK, Ramchand K, Toda M, Chau KY, Bunce C, Webster A, Bird AC, Ono SJ, et al. Circulating anti-retinal antibodies as immune markers in age-related macular degeneration. Immunology. 2005;115:422–30. doi:10.1111/j.1365-2567.2005.02173.x.
   PubMed Web of Science ®Google Scholar
• Penfold PL, Provis JM, Furby JH, Gatenby PA, Billson FA. Autoantibodies to retinal astrocytes associated with age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 1990;228:270–74. doi:10.1007/BF00920033.
   PubMed Web of Science ®Google Scholar
• Kubicka-Trzaska A, Wilanska J, Romanowska-Dixon B, Sanak M. Circulating anti-retinal antibodies in response to anti-angiogenic therapy in exudative age-related macular degeneration. Acta Ophthalmol. 2014;92:e610–4. doi:10.1111/aos.12435.
   PubMed Web of Science ®Google Scholar
• Adamus G, Chew EY, Ferris FL, Klein ML. Prevalence of anti-retinal autoantibodies in different stages of Age-related macular degeneration. BMC Ophthalmol. 2014;14:154. doi:10.1186/1471-2415-14-154.
   PubMed Web of Science ®Google Scholar
• Thirkill CE, Tait RC, Tyler NK, Roth AM, Keltner JL. The cancer-associated retinopathy antigen is a recoverin-like protein. Invest Ophthalmol Vis Sci.1992;33:2768–72.
   PubMed Web of Science ®Google Scholar
• Heckenlively JR, Jordan BL, Aptsiauri N. Association of antiretinal antibodies and cystoid macular edema in patients with retinitis pigmentosa. Am J Ophthalmol. 1999;127:565–73. doi:10.1016/S0002-9394(98)00446-2.
   PubMed Web of Science ®Google Scholar
• Shimazaki K, Jirawuthiworavong GV, Heckenlively JR, Gordon LK. Frequency of anti-retinal antibodies in normal human serum. J Neuroophthalmol. 2008;28:5–11. doi:10.1097/WNO.0b013e318167549f.
   PubMed Web of Science ®Google Scholar
• Ten Berge JC, Schreurs MW, Vermeer J, Meester-Smoor MA, Rothova A. Prevalence and clinical impact of antiretinal antibodies in uveitis. Acta Ophthalmol. 2016;94:282–88. doi:10.1111/aos.12939.
   PubMed Web of Science ®Google Scholar
• Ossewaarde-Van Norel J, Camfferman LP, Rothova A. Discrepancies between fluorescein angiography and optical coherence tomography in macular edema in uveitis. Am J Ophthalmol. 2012;154:233–39. doi:10.1016/j.ajo.2012.02.003.
   PubMed Web of Science ®Google Scholar
• Nakazawa T, Kayama M, Ryu M, Kunikata H, Watanabe R, Yasuda M, Kinugawa J, Vavvas D, Miller JW. Tumor necrosis factor-alpha mediates photoreceptor death in a rodent model of retinal detachment. Invest Ophthalmol Vis Sci. 2011;52:1384–91. doi:10.1167/iovs.10-6509.
   PubMed Web of Science ®Google Scholar
• Yui R, Kunikata H, Aizawa N, Nakazawa T. Anterior chamber aqueous flare and optic nerve microcirculation in eyes with rhegmatogenous retinal detachment. Acta Ophthalmol. 2016;94:e520–1. doi:10.1111/aos.12970.
   PubMed Web of Science ®Google Scholar
• Kunikata H, Yasuda M, Aizawa N, Tanaka Y, Abe T, Nakazawa T. Intraocular concentrations of cytokines and chemokines in rhegmatogenous retinal detachment and the effect of intravitreal triamcinolone acetonide. Am J Ophthalmol. 2013;155(1028–37):e1. doi:10.1016/j.ajo.2013.01.013.
   PubMed Web of Science ®Google Scholar
• Nakazawa T, Hisatomi T, Nakazawa C, Noda K, Maruyama K, She H, Matsubara A, Miyahara S, Nakao S, Yin Y, et al. Monocyte chemoattractant protein 1 mediates retinal detachment-induced photoreceptor apoptosis. Proc Natl Acad Sci U S A. 2007;104:2425–30. doi:10.1073/pnas.0608167104.
   PubMed Web of Science ®Google Scholar
• Nakazawa T, Matsubara A, Noda K, Hisatomi T, She H, Skondra D, Miyahara S, Sobrin L, Thomas KL, Chen DF, et al. Characterization of cytokine responses to retinal detachment in rats. Mol Vis.2006;12:867–78.
   PubMed Web of Science ®Google Scholar
• Kunikata H, Fujita K, Nishiguchi KM, Nakazawa T. Prevalence of antiretinal antibodies in epiretinal membranes and macular holes. Clin Exp Ophthalmol. 2017;
   Google Scholar